Grants Recently Awarded

Augusta Health School of Clinical Laboratory Science, September 2020:  $55,748

Project Title:  Virginia Clinical Laboratory Science Program Support

Purpose:  The August Health CLS school is an accredited, hospital-based laboratory science program in Central Virginia.  The grant will be used to replace outdated equipment (20-30 years old) and to purchase additional new equipment for the blood bank section of the student laboratory.  These purchases will significantly enhance the students’ blood bank education and provide a favorable impression for future enrollment in the program.

Old Dominion University School of Clinical Laboratory Science, September 2020:  $141,625
Project Title:  Virginia Clinical Laboratory Science Program Support

Purpose:  The grant will allow ODU to add 2 new methods to the blood bank student laboratory – gel testing and solid-phase testing.  These methods are rapidly replacing the standard testing method in hospital blood banks.  The addition of this equipment will ensure that ODU graduates are well prepared for future employment in the clinical laboratory.  Ninety percent of the grant will be used to purchase equipment, and the remaining 10% will be used for reagents and supplies. 

Virginia Commonwealth University MLS Program, September 2020:  $11,500

Project Title:  Virginia Clinical Laboratory Science Program Support

Purpose:  The grant from CTF will provide educational assistance in the form of reagents for the blood bank section of the student laboratory and financial hardship assistance to 3 MLS students for travel expenses related to a clinical rotation in flow cytometry and molecular diagnostics.

Blood Centers of America (BCA), August 2020:  $200,000

Project Title:  GOLD Databank (Geodatabase Optimization for the Location of Donors

Purpose: The GOLD suite of analytics will provide actionable data to help identify new blood center locations, enhance operational efficiency, and optimize marketing strategies for blood donations.  This award reflects CTF's commitment to research on novel approaches to donor recruitment to ensure an adequate, post-pandemic blood supply in the United States.

Blood Centers of America (BCA), April 2020:  $60,000

Project Title:  Development of Industry Data Collection Plan

Purpose:  The need for timely and accurate data for the U.S. blood industry is widely recognized, but a national data center capable of collecting and disseminating this information does not exist.  BCA will pull together a working group to develop a plan for a national data collection center.

American Association of Blood Banks (AABB), March 2020:  $36,000

Project Title:  COVID-19 eCast – Town Hall Series

Purpose:  The 2019 Novel Coronavirus (COVID-19) pandemic is having a devastating impact on the U.S. blood supply. To assist blood center and hospital employees navigate their most pressing challenges, AABB developed an education series featuring four, virtual town hall lectures on managing collections, operations, and inventory during a pandemic.


Oklahoma Blood Institute (OBI), March 2020:  $284,620

Project Title:  Study of Alternate Source of Raw Material for Human Platelet Lysate (HPL) For Use In Cell Culture Media

 Purpose:  This project has two objectives: 1) Establish that platelets can be harvested from whole blood units that have been refrigerated; and 2) Determine whether HPL manufactured using refrigerated platelets is substantially equivalent to current HPL formulations manufactured from expired platelets. Platelets used for transfusion are dependent upon attributes of the cell membrane, such as adhesiveness and activation signaling. Refrigeration prior to production could alter these characteristics and leave the units unsuitable for use in patients. However, platelets that are used in tissue culture media are purposely broken apart or lysed. The contents of the platelets, not the cell membrane, are the “active” ingredients needed in HPL.  The hypothesis is that platelets can be successfully removed from refrigerated whole blood and remain suitable for making HPL.


American Association of Blood Banks (AABB), October 2019:  $24,000

Project Title:  AABB 2019 Annual Meeting:  Blood Center Executive Summit

Purpose:  The AABB Blood Center Executive Summit focused on the intersection of blood centers and plasma centers.  Attendees included U.S. blood center chief executive officers as well as the AABB board of directors.  Attendees and presenters explored the risk and benefits of volunteer versus paid donor models, the risks and benefits of the different models, and identified gaps in data related to donor motivation and blood trends.


Annual AABB Meeting Grant Recipients, October 2019

Project Title:   CTF Scholarship to 2019 Annual AABB Meeting in San Antonio, TX.

Purpose:  Laboratory professionals interested in learning about the latest technology affecting the blood banking industry were encouraged to apply.  Scholarship recipients were chosen based on demonstrated dedication and contributions to the field.  Four applicants were awarded scholarships that included full registration for the event, travel, food, and lodging expenses.  Those selected for scholarships were asked to deliver a presentation about what they learned at the annual meeting upon returning to their workplace.


Virginia Commonwealth University (VCU), September 2019:  $16,510

Project Title:  Patient Blood Management Programs (PBM) and Their Association with Patient and Organizational Outcomes

Purpose:  This project will seek to standardize a definition of Patient Blood Management while examining the effect of organizational and environmental factors on the likelihood of a hospital having a formal PBM program. While previous studies have examined the effects of PBM programs on patient and organizational outcomes at single hospitals or within a hospital system, this project will examine a larger population of hospitals and may provide more generalizable inferences about the associations between PBM programs and patient and organizational outcomes.  Hospitals will be able to use this knowledge to guide policy toward quality improvement initiatives in patient blood management.


Radford University (RU) School of Medical Laboratory Science
September 2019:  $25,000

Project Title:  Support of RU Medical Laboratory Science Program

Purpose:  The grant was requested to purchase materials and supplies to support hands-on exercises in Immunohematology, prepare the students for the pre-analytical phase of testing, and enhance their preparation for practice in the clinical laboratory. 


Virginia Commonwealth University (VCU), September 2019:  $48,307

Project Title:  Support of VCU Medical Laboratory Science Program 

Purpose:  The grant was requested to purchase new equipment for the student laboratory, including 2 Ortho Gel Workstations, to ensure that all MLS students gain experience in performing advanced techniques during the blood banking portion of the program.


Eastern Virginia Medical School, May 2019:  $135,460

Project Title:  Optimization of P1C1 Treatment in a Rat Model of Transfusion Related Acute Lung Injury (TRALI)

Purpose:   Transfusion-related adverse reactions are rare in the developed world due to current safety checks. However, transfusion reactions do still occur with transfusion-related acute lung injury (TRALI) reported as the leading cause of transfusion mortality in the United States. It is estimated that the incidence of TRALI is between 1/1333-1/5000 per unit transfused in North America with a mortality rate of between 5-35%.  Researchers at the Eastern Virginia Medical School (EVMS) have discovered a novel inhibitor of the classical pathway of complement, called Peptide Inhibitor of Complement C1 (PIC1) that can prevent as well as treat acute intravascular hemolytic transfusion reaction (AIHTR) in an animal model.  For this project, they propose to further test the role of PIC1 in preventing TRALI in a rat model.